ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 1 filers reported holding ASCENDIS PHARMA A/S in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $694,341 | +4.9% | 7,415 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $661,789 | -88.4% | 7,415 | -86.0% | 0.00% | -85.7% |
Q1 2023 | $5,686,411 | +86.4% | 53,035 | +112.4% | 0.01% | +75.0% |
Q4 2022 | $3,050,196 | +94.7% | 24,975 | +64.6% | 0.00% | +100.0% |
Q3 2022 | $1,566,454 | – | 15,170 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vivo Capital, LLC | 2,046,832 | $240,912,000 | 24.02% |
RA Capital Management | 4,132,442 | $486,388,000 | 20.97% |
VHCP Management II, LLC | 504,210 | $59,346,000 | 17.36% |
Ghost Tree Capital, LLC | 385,000 | $45,315,000 | 11.84% |
Sofinnova Investments, Inc. | 998,538 | $117,528,000 | 11.33% |
Foresite Capital Management IV, LLC | 245,424 | $28,886,000 | 10.38% |
Avoro Capital Advisors LLC | 1,795,000 | $211,272,000 | 9.14% |
Orbimed Advisors | 3,970,673 | $467,348,000 | 7.24% |
Eventide Asset Management | 1,698,648 | $199,931,000 | 6.88% |
Foresite Capital Management III, LLC | 204,088 | $24,021,000 | 6.25% |